- Home
- TBPH vs AGNT Comparison
TBPH vs AGNT Comparison
Compare TBPH & AGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TBPH | AGNT |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.9M | 815.0M |
| IPO Year | 2013 | 2010 |
Fundamental Metrics
Financial Performance| Metric | TBPH | AGNT |
|---|---|---|
| Price | $17.03 | $4.50 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.40 | N/A |
| AVG Volume (30 Days) | 377.6K | ★ 1.5M |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,386,000.00 | ★ $500,147,681.00 |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 220.39 |
| 52 Week Low | $13.08 | $3.66 |
| 52 Week High | $21.03 | $5.79 |
Technical Indicators
Market Signals| Indicator | TBPH | AGNT |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 52.79 |
| Support Level | $16.80 | $4.20 |
| Resistance Level | $17.17 | $4.77 |
| Average True Range (ATR) | 0.05 | 0.25 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 93.75 | 68.78 |
Price Performance
Historical ComparisonAbout TBPH Theravance Biopharma Inc.
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
About AGNT AGNT Inc. Common Stock
AGNT Inc is a multi-model real estate platform, with brands including eXp Realty, eXp Commercial, NextHome, FrameVR.io, and SUCCESS Enterprises. The group prioritizes transparency, innovation, and long-term value for agents, franchise owners, staff, and shareholders.